Lucid Diagnostics (LUCD) SEC Filings & 10K Form

$0.95
-0.08 (-7.77%)
(As of 05/8/2024 ET)

Recent Lucid Diagnostics SEC Filings

DateFilerForm TypeView
05/07/2024
6:50 AM
Lucid Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
7:41 PM
Lucid Diagnostics (Filer)
Form PRE 14A
03/25/2024
4:21 PM
Lucid Diagnostics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/14/2024
7:00 AM
Lucid Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
3:49 PM
Lucid Diagnostics (Issuer)
White Debra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:37 PM
Lucid Diagnostics (Issuer)
SOKOLOV JACQUE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
3:45 PM
Lucid Diagnostics (Subject)
PAVmed Inc. (Filed by)
PAVmed Inc. (Filed by)
Form SC 13D/A
02/20/2024
3:49 PM
Lucid Diagnostics (Issuer)
PAVmed Inc. (Reporting)
PAVmed Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:38 PM
Ayrton Capital LLC (Filed by)
Lucid Diagnostics (Subject)
Form SC 13G
02/06/2024
4:20 PM
Lucid Diagnostics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/06/2024
4:24 PM
Lucid Diagnostics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/02/2024
4:11 PM
Lucid Diagnostics (Subject)
PAVmed Inc. (Filed by)
PAVmed Inc. (Filed by)
Form SC 13D/A
01/30/2024
4:29 PM
Lucid Diagnostics (Issuer)
PAVmed Inc. (Reporting)
PAVmed Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
4:00 PM
Lucid Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
3:05 PM
Lucid Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
8:40 PM
Lucid Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
4:15 PM
Lucid Diagnostics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2023
3:35 PM
Lucid Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2023
3:21 PM
Lucid Diagnostics (Filer)
Form D
Notice of Exempt Offering of Securities 
10/18/2023
8:15 AM
Lucid Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
7:53 PM
Lapidus Stanley (Reporting)
Lucid Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
7:50 PM
Lapidus Stanley (Reporting)
Lucid Diagnostics (Issuer)
Form 4/A
09/26/2023
8:55 PM
Lapidus Stanley (Reporting)
Lucid Diagnostics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/22/2023
5:39 PM
Lapidus Stanley (Reporting)
Lucid Diagnostics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
3:45 PM
Lucid Diagnostics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/21/2023
4:00 PM
Lucid Diagnostics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2023
11:15 PM
Lucid Diagnostics (Filer)
Form EFFECT
05/22/2023
7:49 PM
Lucid Diagnostics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:LUCD) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners